Health Care: Drugs

NewLink Genetics Corp (NLNK: NASDAQ)

$11.03 n/a | n/a%
07/22/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 68.50M 172.59M 1.09M 1.69M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 68.50M 172.59M 1.09M 1.69M
Selling, General, and Administrative Expenses 30.69M 19.33M 9.52M 7.11M
Research & Development 71.41M 35.69M 22.71M 17.84M
Operating Income before D & A (EBITDA) -33.60M 117.57M -31.14M -23.26M
Depreciation & Amortization 1.59M 1.10M 891.00K 788.00K
Interest Income 78.00K 86.00K 12.00K 14.00K
Other Income - Net -14.00K 0.00 112.00K -38.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -35.13M 116.56M -31.91M -24.07M
Interest Expense 105.00K 26.00K 33.00K 38.00K
Pre-Tax Income -35.23M 116.54M -31.94M -24.11M
Income Taxes 6.74M 14.78M 130.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -40.38M 102.86M -31.18M -23.32M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -40.38M 102.86M -31.18M -23.32M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -40.38M 102.86M -31.18M -23.32M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-40.38M 102.86M -31.18M -23.32M
Preferred Dividends
Net Income Available To Common -40.38M 102.86M -31.18M -23.32M
Basic EPS from Continuing Ops. -1.41 3.69 -1.23 -1.12
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.41 3.69 -1.23 -1.12
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.41 3.69 -1.23 -1.12
Basic Normalized Net Income/Share -1.41 3.69 -1.23 -1.12
EPS fr Continuing Ops. -1.41 3.32 -1.23 -1.12
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.41 3.32 -1.23 -1.12
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.41 3.32 -1.23 -1.12
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.41 3.32 -1.23 -1.12
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NLNK

Latest NLNK Headlines from TheStreet

More Financial News for NLNK

Press Releases for NLNK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter